Table 2. Comparison of chemosensitivity in the MDA-MB-435S-F cell line and its doxorubicin selected variants.
|
IC50 (ng ml−1) |
|||||
|---|---|---|---|---|---|
| Drug | MDA-MB- 435S-F | MDA-MB-435S- F/Adr-10p | Fold resistance of MDA-MB-435S-F/Adr-10p | MDA-MB-435S- F/Adr-10p10p | Fold resistance of MDA-MB-435S-F/Adr-10p10p |
| Doxorubicin | 271±3 | 316±15 | 1.16 | 381±11.54** | 1.40 |
| Paclitaxel | 28.3±1.52 | 20.3±2.1* | 0.71 | 17.6±0.2* | 0.62 |
| Carboplatin | 41 300±1500 | 37 600±1150 | 0.91 | 24 600±1520* | 0.59 |
| Docetaxel | 3.33±0.37 | 3.76±0.20 | 1.12 | 4.76±0.152* | 1.42 |
| VP-16 | 1844±77 | 2663±148** | 1.44 | 3785±79** | 2.05 |
| 5-Fluorouracil | 7430±680 | 3360±400* | 0.45 | 3430±50* | 0.46 |
| Vincristine | 12.9±1.3 | 6.9±0.69** | 0.53 | 32.1±2.5** | 1.61 |
The IC50 values are the mean of a minimum of three repeat experiments.
P<0.05, Student's t-test.
P<0.005, Student's t-test.